Fifth Third Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Fifth Third Wealth Advisors's ABBV Position: Q3 2026 in Review
Fifth Third Wealth Advisors increased its AbbVie (ABBV) stake by 2.9% in Q3 2026, buying an estimated $386K and bringing the position to 52,577 shares worth $13.8M. The position accounts for 0.36% of the portfolio, ranked #50.
Fifth Third Wealth Advisors first reported a position in ABBV in Q1 2023 and has held it in 15 quarters since. 1,321 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Fifth Third Wealth Advisors held 52,577 shares of AbbVie worth $13.8M as of Q3 2026.
- Fifth Third Wealth Advisors bought 1,504 AbbVie shares in Q3 2026, an estimated $386K.
- AbbVie made up 0.36% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #50 holding.
- Fifth Third Wealth Advisors first reported a position in AbbVie in Q1 2023 and has held it in 15 quarters since.
- 1,321 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.